CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Revenues	$ 45,292		$ 45,292	$ 189,500
Operating expenses
Research and development expense	101,517	38,380	260,612	116,790
General and administrative expense	414,583	243,445	776,707	644,771
Total operating expenses	516,100	281,825	1,037,319	761,561
Loss from operations	(470,808)	(281,825)	(992,027)	(572,061)
Other income (expense)
Financing costs	(3,900)		(34,400)
Interest expense	(37,246)	(25,310)	(67,829)	(155,735)
Gain (loss) on settlement of liabilities, net	(27,957)	402,442	(57,971)	1,006,688
Net income (loss)	$ (539,911)	$ 95,307	$ (1,152,227)	$ 278,892
Net income (loss) per share
Basic (in Dollars per share)		$ 0.00		$ 0.00
Diluted (in Dollars per share)		$ 0.00		$ 0.00
Basic and diluted loss per common share (in Dollars per share)	$ 0.00		$ 0.00
Weighted average shares used to compute net income (loss) per share
Basic (in Shares)		184,017,159		167,543,861
Diluted (in Shares)		332,554,613		287,983,773
Basic and diluted weighted average common shares outstanding (in Shares)	547,506,255		532,533,067